HeartBeam, Inc. (BEAT): יחס מחיר להכנסות חזויות

HeartBeam, Inc. (BEAT) aims for global cardiac market dominance by scaling its B2B 3D diagnostics services. The business's forward P/S ratio clearly demonstrates the company's market valuation, where the metric determines this level. The development of portable monitors in the US relies on growing demand for remote monitoring. However, negative cash flow and the anticipation of regulatory approvals leave the business dependent on external investment.

HeartBeam, Inc. (BEAT) expansion into the portable AI ECG monitoring segment provides a foundation for revenue scaling, which is reflected in the dynamics of the expected revenue multiple. This indicator compares current market capitalization with projected sales volume, allowing investors to assess the extent of market expectations currently priced in and determine the boundaries of the business's fair value during its commercial growth phase.